Breyanzi (lisocabtagene maraleucel) - BMS
Imbruvica (ibrutinib) - AbbVie, J&J
Rituxan (rituximab) - Roche
Venclexta (venetoclax) - Roche, AbbVie
ABBV-467 - AbbVie
nemtabrutinib (MK-1026) - Merck (MSD)
AZD4320 - AstraZeneca
Jaypirca (pirtobrutinib) - Eli Lilly
Tecentriq (atezolizumab) - Roche
Opdivo (nivolumab) - Ono Pharma, BMS
voruciclib (ME-522) - MEI
bendamustine - Generic mfg.
Epkinly (epcoritamab-bysp) - Genmab, AbbVie
Zydelig (idelalisib) - Gilead
Calquence (acalabrutinib) - AstraZeneca
zelebrudomide (NX-2127) - Nurix Therap
Gazyva (obinutuzumab) - Roche, Biogen
bexobrutideg (NX-5948) - Nurix Therap
Columvi (glofitamab-gxbm) - Roche
pelcitoclax (APG-1252) - Ascentage Pharma
Keytruda (pembrolizumab) - Merck (MSD)
Brukinsa (zanubrutinib) - BeOne Medicines
sonrotoclax (BGB-11417) - BeOne Medicines
tapotoclax (AMG 176) - Amgen
AZD5991 - AstraZeneca
lisaftoclax (APG-2575) - Ascentage Pharma
Tevimbra (tislelizumab-jsgr) - BeOne Medicines
Polivy (polatuzumab vedotin-piiq) - Roche
catadegbrutinib (BGB-16673) - BeOne Medicines
https://onlinelibrary.wiley.com/doi/10.1002/hon.70064
 
Nathalie Javidi-Sharifi; Matthew S. Davids
 
Jun 16, 2025
 
Next